- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Prehospital Z1 P-REBOA Feasible and may enable early survival in Trauma Patients: JAMA
UK: Z1 P-REBOA is feasible and may enable early survival, but with a significant incidence of late death in the prehospital resuscitation of adult trauma patients at risk of cardiac arrest and death due to exsanguination, a recent study has revealed. The findings were published online in JAMA Surgery.
"In the cohort study involving 16 patients with severe injuries and shock, prehospital zone 1 (supraceliac) partial resuscitative endovascular balloon occlusion of the aorta (Z1 P-REBOA) was successfully administered in 8 out of 11 patients who underwent Z1 REBOA. This approach correlated with enhanced proximal blood pressure (BP) levels and reduced early mortality rates," the researchers reported.
Hemorrhage is the leading preventable cause of death following injury, with the majority occurring during the early prehospital phase of treatment. The P-REBOA procedure involves temporarily inflating a balloon in the aorta to halt blood flow beyond the injury site, thereby stabilizing the patient and buying crucial time for definitive surgical intervention. This approach is particularly crucial for trauma cases where rapid blood loss threatens life within minutes.
Robbie A. Lendrum from Bart’s Health National Health Service Trust in London, United Kingdom, and colleagues aimed to establish whether prehospital zone 1 (supraceliac) partial resuscitative endovascular balloon occlusion of the aorta can be achieved in the resuscitation of adult trauma patients at cardiac arrest and death risk due to exsanguination.
For this purpose, the researchers conducted a prospective observational cohort study with recruitment from 2020 to 2022 and follow-up until death, discharge from the hospital, or 90 days evaluating a physician-led and physician-delivered, urban prehospital trauma service in the Greater London area.
It included trauma patients 16 years and older age with suspected exsanguinating subdiaphragmatic hemorrhage, and recent or imminent hypovolemic traumatic cardiac arrest (TCA). It excluded those with unsurvivable injuries or who were pregnant. Of the 2960 individuals served during the study period, 16 were selected for inclusion.
The primary focus was determining the success rates of achieving Z1 REBOA and Z1 P-REBOA among patients. The key clinical endpoints assessed included the response of systolic BP to Z1 REBOA, mortality rates at various intervals post-injury (1 hour, 3 hours, 24 hours, or 30 days), and the survival rate to hospital discharge.
The study led to the following findings:
- Femoral arterial access for Z1 REBOA was attempted in 16 patients (median age, 30 years; 81% male; median Injury Severity Score, 50).
- In 2 patients with successful arterial access, REBOA was not attempted due to improvement in clinical condition.
- In the other 14 patients (8 of whom were in traumatic cardiac arrest [TCA]), 11 successfully underwent cannulation and had aortic balloons inflated in Z1.
- The three individuals in whom cannulation was unsuccessful were in TCA (failure rate = 3/14 [21%]).
- The median pre-REBOA SBP in the 11 individuals for whom cannulation was successful (5 [46%] in TCA) was 47 mm Hg.
- Z1 REBOA plus P-REBOA was associated with a significant improvement in BP (median SBP at emergency department arrival, 101 mm Hg; 0 of 10 patients were in TCA at arrival).
- The median group-level improvement in SBP from the pre-REBOA value was 52 mm Hg.
- P-REBOA was feasible in 8 individuals (8/11 [73%]) and occurred spontaneously in 4.
- The 1- and 3-hour postinjury mortality rate was 9%, 24-hour mortality was 27%, and 30-day mortality was 82%.
- Survival to hospital discharge was 18%. Both survivors underwent early Z1 P-REBOA.
The study showed the feasibility of prehospital Z1 P-REBOA using distal pressure as a surrogate for flow for the resuscitation of exsanguinating trauma patients at risk of imminent prehospital death.
"This approach led to higher proximal blood pressure levels, maintained hemodynamic stability, and potentially facilitated early survival. However, it was also associated with a notable incidence of multiple organ dysfunction syndrome and delayed mortality," the researchers concluded.
Reference:
Lendrum RA, Perkins Z, Marsden M, et al. Prehospital Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Exsanguinating Subdiaphragmatic Hemorrhage. JAMA Surg. Published online July 10, 2024. doi:10.1001/jamasurg.2024.2254
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751